Product Theater:
Astrazeneca

WHEN: Sun, Oct 25 // 1:15 pm - 2:15 pm (ET)

IN-PERSON: Seaport Ballroom (Mezzanine / Level 2)
LIVESTREAM: Yes | ON-DEMAND: No

LUNCH SERVED

New Data on ATTR-CM for Health Care Providers From CARDIO-TTRansform

Join an AstraZeneca- and Ionis-sponsored session presenting phase 3 trial results for an investigational treatment for transthyretin amyloid cardiomyopathy (ATTR-CM).

Speaker:

Margaret Cuomo, NP
Astrazeneca

BACK TO MAIN PRODUCT THEATERS PAGE